Spacer / holding chamber device - Chronic Obstructive Pulmonary Disease (COPD)
You are here : Home > Formulary Search > Spacer / holding chamber device - Chronic Obstructive Pulmonary Disease (COPD)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Spacer device
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
AeroChamber Plus Flow-Vu Anti-Static - from 13 years
Status 2
Green
Formulations :
- Spacer device
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Volumatic - fFrom 5 years. Compatible with Clenil Modulite, Salamol and Seretide
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Spacer / holding chamber device
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
Keywords :
Brand Names Include :
Aerochamber Plus Flow-Vu Anti-Static, Volumatic
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Spacer / holding chamber device is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).
- Aclidinium bromide (Eklira Genuair)
- Aclidinium with formoterol (Duaklir Genuair)
- Beclometasone with formoterol (Fostair NEXThaler 100/6)
- Beclometasone with formoterol (Fostair)
- Beclometasone with formoterol (Proxor 100/6)
- Beclometasone with formoterol and glycopyrronium (Trimbow 87/5/9)
- Beclometasone with formoterol and glycopyrronium (Trimbow NEXThaler)
- Budesonide nebules
- Budesonide with formoterol (DuoResp Spiromax)
- Budesonide with formoterol (Fobumix Easyhaler)
- Budesonide with formoterol (Symbicort 200/6)
- Budesonide with formoterol (Symbicort Turbohaler 400/12)
- Dupilumab
- Fluticasone with salmeterol (Fusacomb Easyhaler)
- Fluticasone with salmeterol (Seretide Accuhaler)
- Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta)
- Fluticasone with vilanterol (Relvar Ellipta)
- Formoterol (Easyhaler Formoterol)
- Formoterol (Oxis Turbohaler)
- Glycopyrronium (Seebri Breezhaler)
- Glycopyrronium with formoterol (Bevespi Aerosphere)
- Glycopyrronium with indacaterol (Ultibro Breezhaler)
- Indacaterol (Onbrez Breezhaler)
- Ipratropium (Atrovent)
- Ipratropium (nebules)
- Ipratropium with salbutamol (nebules)
- Olodaterol (Striverdi Respimat)
- Roflumilast
- Salbutamol (Easyhaler Salbutamol)
- Salbutamol (nebules)
- Salbutamol (Salamol Easi-Breathe)
- Salbutamol (Salamol)
- Salbutamol (Salbulin Novolizer)
- Salbutamol (Ventolin Accuhaler)
- Salbutamol (Ventolin Evohaler)
- Salmeterol (Serevent Evohaler / Serevent Accuhaler)
- Spacer / holding chamber device with mask
- Terbutaline (Bricanyl Turbohaler)
- Terbutaline (nebules / injection)
- Tiotropium (Braltus Zonda)
- Tiotropium (Spiriva HandiHaler)
- Tiotropium bromide (Spiriva Respimat)
- Tiotropium with olodaterol (Spiolto Respimat)
- Umeclidinium (Incruse Ellipta)
- Umeclidinium with vilanterol (Anoro Ellipta)
Committee Recommendations (1)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.